Scientists from the world’s largest vaccine maker and head of the World Health Organization say the globally scarce ingredients are needed to manufacture the corona virus vaccine. Adar Poonawala, chief executive officer of the Serum Institute of India Limited, told a World Bank panel on Thursday that US law would impose a serious barrier on the export of certain important commodities, including bags and filters for vaccines.

Please tell us that the serum is licensed to produce Cro-19 vaccines from AstraZeneca and Novavax. Poonawalla said the material was needed because it was a major manufacturer of the Novavax vaccine. If we talk about making vaccines for the whole world, we are going to have problems with this important raw material. He said no one had talked about this yet.

In fact, all of these issues have been announced by the Biden administration to implement the Defense Manufacturing Act to accelerate the vaccination program in the US. Since then, the remaining companies have had difficulties in exporting raw materials. Poonawala said the Biden administration needed to discuss this. Poonawalla said that in the last two months, 90 million doses of octrazeneca vaccine were sent abroad after India’s vaccine was approved for emergency use.